Craig Hettenbach
Stock Analyst at Morgan Stanley
(2.69)
# 2,000
Out of 4,876 analysts
295
Total ratings
57.25%
Success rate
-1.33%
Average return
Main Sectors:
Stocks Rated by Craig Hettenbach
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HNGE Hinge Health | Initiates: Overweight | $46 | $44.35 | +3.73% | 1 | Jun 16, 2025 | |
| HIMS Hims & Hers Health | Reiterates: Equal-Weight | $40 | $49.62 | -19.39% | 4 | Jun 11, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $175 → $210 | $173.89 | +20.77% | 3 | Jun 9, 2025 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $355 → $410 | $380.60 | +7.72% | 3 | Jun 9, 2025 | |
| VEEV Veeva Systems | Maintains: Underweight | $201 → $210 | $280.90 | -25.24% | 8 | May 29, 2025 | |
| UHS Universal Health Services | Initiates: Equal-Weight | $200 | $180.48 | +10.82% | 1 | Mar 26, 2025 | |
| ARDT Ardent Health | Maintains: Overweight | $24 → $22 | $13.43 | +63.81% | 2 | Jan 21, 2025 | |
| AMWL American Well | Maintains: Equal-Weight | $20 → $11 | $7.48 | +40.37% | 5 | Dec 17, 2024 | |
| GDRX GoodRx Holdings | Maintains: Equal-Weight | $7 → $6 | $4.99 | +20.36% | 2 | Dec 17, 2024 | |
| SLAB Silicon Laboratories | Maintains: Equal-Weight | $123 → $97 | $148.30 | -34.59% | 14 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $9 → $5 | $3.78 | +32.45% | 12 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $96 → $114 | $74.90 | +52.20% | 24 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $62 → $57 | $30.28 | +88.24% | 19 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $81 | $71.05 | +14.00% | 23 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $35 | $60.75 | -42.39% | 4 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $20.64 | -12.77% | 4 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $208 → $185 | $83.76 | +120.87% | 23 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $162 → $167 | $168.99 | -1.18% | 23 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $42 → $42 | $97.10 | -56.75% | 25 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $159 | $177.16 | -10.25% | 2 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $125 | $68.06 | +83.66% | 3 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $72 | $269.18 | -73.14% | 22 | Dec 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $193 → $195 | $207.04 | -5.82% | 3 | Oct 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $488 | $304.81 | +60.10% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $297 → $296 | $292.24 | +1.29% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $273 → $368 | $257.66 | +42.82% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $513 | $240.46 | +113.34% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $321 → $275 | $331.65 | -17.08% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $94 → $88 | $53.71 | +63.84% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | n/a | $53.51 | - | 11 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $173 → $185 | $66.00 | +180.32% | 2 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $190 → $213 | $220.02 | -3.19% | 19 | Apr 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $53 → $58 | $110.26 | -47.40% | 12 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $101 → $117 | $238.18 | -50.88% | 15 | Jun 16, 2020 |
Hinge Health
Jun 16, 2025
Initiates: Overweight
Price Target: $46
Current: $44.35
Upside: +3.73%
Hims & Hers Health
Jun 11, 2025
Reiterates: Equal-Weight
Price Target: $40
Current: $49.62
Upside: -19.39%
Tenet Healthcare
Jun 9, 2025
Maintains: Overweight
Price Target: $175 → $210
Current: $173.89
Upside: +20.77%
HCA Healthcare
Jun 9, 2025
Maintains: Equal-Weight
Price Target: $355 → $410
Current: $380.60
Upside: +7.72%
Veeva Systems
May 29, 2025
Maintains: Underweight
Price Target: $201 → $210
Current: $280.90
Upside: -25.24%
Universal Health Services
Mar 26, 2025
Initiates: Equal-Weight
Price Target: $200
Current: $180.48
Upside: +10.82%
Ardent Health
Jan 21, 2025
Maintains: Overweight
Price Target: $24 → $22
Current: $13.43
Upside: +63.81%
American Well
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $20 → $11
Current: $7.48
Upside: +40.37%
GoodRx Holdings
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $7 → $6
Current: $4.99
Upside: +20.36%
Silicon Laboratories
Nov 5, 2024
Maintains: Equal-Weight
Price Target: $123 → $97
Current: $148.30
Upside: -34.59%
Aug 6, 2024
Maintains: Equal-Weight
Price Target: $9 → $5
Current: $3.78
Upside: +32.45%
Feb 7, 2023
Maintains: Equal-Weight
Price Target: $96 → $114
Current: $74.90
Upside: +52.20%
Jun 10, 2022
Maintains: Overweight
Price Target: $62 → $57
Current: $30.28
Upside: +88.24%
Jun 10, 2022
Maintains: Overweight
Price Target: $85 → $81
Current: $71.05
Upside: +14.00%
May 18, 2022
Maintains: Equal-Weight
Price Target: $55 → $35
Current: $60.75
Upside: -42.39%
Mar 28, 2022
Maintains: Overweight
Price Target: $20 → $18
Current: $20.64
Upside: -12.77%
Feb 3, 2022
Maintains: Overweight
Price Target: $208 → $185
Current: $83.76
Upside: +120.87%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $162 → $167
Current: $168.99
Upside: -1.18%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $42 → $42
Current: $97.10
Upside: -56.75%
Dec 17, 2021
Maintains: Equal-Weight
Price Target: $165 → $159
Current: $177.16
Upside: -10.25%
Dec 13, 2021
Maintains: Overweight
Price Target: $115 → $125
Current: $68.06
Upside: +83.66%
Dec 10, 2021
Maintains: Overweight
Price Target: $57 → $72
Current: $269.18
Upside: -73.14%
Oct 27, 2021
Maintains: Underweight
Price Target: $193 → $195
Current: $207.04
Upside: -5.82%
Aug 31, 2021
Maintains: Overweight
Price Target: $515 → $488
Current: $304.81
Upside: +60.10%
Aug 31, 2021
Maintains: Overweight
Price Target: $297 → $296
Current: $292.24
Upside: +1.29%
Aug 31, 2021
Maintains: Overweight
Price Target: $273 → $368
Current: $257.66
Upside: +42.82%
Aug 31, 2021
Maintains: Overweight
Price Target: $500 → $513
Current: $240.46
Upside: +113.34%
Aug 31, 2021
Maintains: Overweight
Price Target: $321 → $275
Current: $331.65
Upside: -17.08%
Aug 31, 2021
Maintains: Overweight
Price Target: $94 → $88
Current: $53.71
Upside: +63.84%
Aug 3, 2021
Upgrades: Equal-Weight
Price Target: n/a
Current: $53.51
Upside: -
May 7, 2021
Maintains: Overweight
Price Target: $173 → $185
Current: $66.00
Upside: +180.32%
Apr 8, 2021
Downgrades: Equal-Weight
Price Target: $190 → $213
Current: $220.02
Upside: -3.19%
Feb 11, 2021
Maintains: Equal-Weight
Price Target: $53 → $58
Current: $110.26
Upside: -47.40%
Jun 16, 2020
Maintains: Equal-Weight
Price Target: $101 → $117
Current: $238.18
Upside: -50.88%